ArticleMolecular therapy. Advances2026

Preclinical evaluation of AAV2 anti-VEGF gene therapy using scFv for choroidal neovascularization.

Xin Xu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.